Bombus terrestris chromosome 8, iyBomTerr1.2, whole genome shotgun sequence.
Bombus terrestris (buff-tailed bumblebee)
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Apoidea; Apidae; Bombus; Bombus.
REFSEQ INFORMATION: The reference sequence is identical to\nOU342928.1.\nAssembly name: iyBomTerr1.2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2022/02/09. The original whole-genome shotgun project has the\naccession CAJUYY000000000.2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Bombus terrestris Annotation Release\n 103\nAnnotation Version :: 103\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
octopamine receptor beta-3R, transcript variant X3
COORDINATES: polyA evidence [ECO:0006239]
octopamine receptor beta-3R, transcript variant X2
octopamine receptor beta-3R, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
octopamine receptor beta-1R, transcript variant X3
octopamine receptor beta-1R, transcript variant X1
octopamine receptor beta-1R, transcript variant X2
ubiquitin thioesterase trabid, transcript variant X1
ubiquitin thioesterase trabid, transcript variant X2
NADPH-dependent diflavin oxidoreductase 1, transcript variant X5
NADPH-dependent diflavin oxidoreductase 1 isoform X5
NADPH-dependent diflavin oxidoreductase 1, transcript variant X2
NADPH-dependent diflavin oxidoreductase 1, transcript variant X1
NADPH-dependent diflavin oxidoreductase 1, transcript variant X3
equilibrative nucleoside transporter 1 isoform X1
equilibrative nucleoside transporter 1 isoform X2
NADPH-dependent diflavin oxidoreductase 1, transcript variant X4
equilibrative nucleoside transporter 1 isoform X4
equilibrative nucleoside transporter 1 isoform X3
C-terminal-binding protein, transcript variant X5
C-terminal-binding protein, transcript variant X1
C-terminal-binding protein, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 133 samples with support for all annotated introns
C-terminal-binding protein, transcript variant X6
uncharacterized LOC110119499, transcript variant X1
uncharacterized LOC110119499, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
C-terminal-binding protein, transcript variant X2
C-terminal-binding protein, transcript variant X4
C-terminal-binding protein, transcript variant X3
uncharacterized LOC110119514, transcript variant X5
ATP-binding cassette sub-family D member, transcript variant X2
ATP-binding cassette sub-family D member, transcript variant X1
ATP-binding cassette sub-family D member isoform X2
ATP-binding cassette sub-family D member isoform X1
uncharacterized LOC110119514, transcript variant X1
uncharacterized LOC110119514, transcript variant X3
uncharacterized LOC110119514, transcript variant X2
uncharacterized LOC110119514, transcript variant X4
uncharacterized LOC110119514, transcript variant X6
uncharacterized LOC110119514, transcript variant X7
uncharacterized LOC100648281, transcript variant X2
uncharacterized LOC100648281, transcript variant X1
uncharacterized LOC100648281, transcript variant X3
uncharacterized LOC125385538, transcript variant X1
uncharacterized LOC125385538, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
uncharacterized LOC100650602, transcript variant X7
uncharacterized protein LOC100650602 isoform X3
uncharacterized LOC100650602, transcript variant X6
uncharacterized LOC100650602, transcript variant X2
uncharacterized LOC100650602, transcript variant X1
uncharacterized LOC100650602, transcript variant X3
uncharacterized LOC100650602, transcript variant X4
uncharacterized LOC100650602, transcript variant X9
uncharacterized LOC100650602, transcript variant X10
uncharacterized LOC100650602, transcript variant X8
uncharacterized protein LOC100650602 isoform X4
uncharacterized LOC100650602, transcript variant X5
uncharacterized protein LOC100650602 isoform X1
uncharacterized protein LOC100650602 isoform X2
uncharacterized protein LOC100650602 isoform X5
transcriptional activator protein Pur-beta, transcript variant X4
transcriptional activator protein Pur-beta isoform X4
transcriptional activator protein Pur-beta, transcript variant X1
transcriptional activator protein Pur-beta, transcript variant X2
transcriptional activator protein Pur-beta isoform X1
transcriptional activator protein Pur-beta isoform X2
transcriptional activator protein Pur-beta, transcript variant X6
transcriptional activator protein Pur-beta isoform X6
transcriptional activator protein Pur-beta, transcript variant X3
transcriptional activator protein Pur-beta isoform X3
transcriptional activator protein Pur-beta, transcript variant X5
transcriptional activator protein Pur-beta isoform X5
uncharacterized LOC100643696, transcript variant X1
uncharacterized LOC100643696, transcript variant X2
uncharacterized protein LOC100643696 isoform X1
uncharacterized protein LOC100643696 isoform X2
uncharacterized LOC110119515, transcript variant X1
uncharacterized LOC110119515, transcript variant X2
uncharacterized LOC110119515, transcript variant X3
uncharacterized protein LOC110119515 isoform X1
uncharacterized protein LOC110119515 isoform X2
probable 39S ribosomal protein L23, mitochondrial, transcript variant X2
probable 39S ribosomal protein L23, mitochondrial, transcript variant X1
probable 39S ribosomal protein L23, mitochondrial
potassium channel subfamily K member 18, transcript variant X1
potassium channel subfamily K member 18, transcript variant X4
potassium channel subfamily K member 18, transcript variant X3
potassium channel subfamily K member 18, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC100646149, transcript variant X3
uncharacterized LOC100646149, transcript variant X2
uncharacterized LOC100646149, transcript variant X1
RNA polymerase II subunit A C-terminal domain phosphatase SSU72
RNA-binding protein 48, transcript variant X2
RNA-binding protein 48, transcript variant X3
RNA-binding protein 48, transcript variant X1
uncharacterized LOC100647341, transcript variant X1
uncharacterized LOC100647341, transcript variant X2
uncharacterized protein LOC100647341 isoform X2
uncharacterized protein LOC100647341 isoform X1
zinc finger protein 724, transcript variant X3
zinc finger protein 724, transcript variant X4
zinc finger protein 724, transcript variant X1
zinc finger protein 724, transcript variant X2
threonine--tRNA ligase 1, cytoplasmic, transcript variant X2
threonine--tRNA ligase 1, cytoplasmic, transcript variant X1
threonine--tRNA ligase 1, cytoplasmic isoform X2
threonine--tRNA ligase 1, cytoplasmic isoform X1
zinc finger protein DPF3, transcript variant X1
zinc finger protein DPF3, transcript variant X4
zinc finger protein DPF3, transcript variant X3
zinc finger protein DPF3, transcript variant X2
ribosomal protein S6 kinase alpha-5, transcript variant X2
ribosomal protein S6 kinase alpha-5, transcript variant X3
ribosomal protein S6 kinase alpha-5, transcript variant X1
ribosomal protein S6 kinase alpha-5 isoform X2
ribosomal protein S6 kinase alpha-5 isoform X1
ribosomal protein S6 kinase alpha-5, transcript variant X4
ribosomal protein S6 kinase alpha-5 isoform X3
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon ACG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
pyrokinin-1 receptor, transcript variant X2
pyrokinin-1 receptor, transcript variant X1
neutral ceramidase, transcript variant X1
neutral ceramidase, transcript variant X2
neutral ceramidase, transcript variant X3
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1, transcript variant X2
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1, transcript variant X1
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 isoform X1
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 isoform X2
uncharacterized LOC105665982, transcript variant X2
uncharacterized LOC105665982, transcript variant X1
uncharacterized LOC100648637, transcript variant X2
uncharacterized LOC100648637, transcript variant X3
uncharacterized LOC100648637, transcript variant X1
uncharacterized protein LOC100648637 isoform X1
uncharacterized protein LOC100648637 isoform X3
uncharacterized protein LOC100648637 isoform X2
cyclic AMP-responsive element-binding protein 3-like protein 2
GATA zinc finger domain-containing protein 14-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 34% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 16% coverage of the annotated genomic feature by RNAseq alignments
transient-receptor-potential-like protein, transcript variant X3
transient-receptor-potential-like protein, transcript variant X1
transient-receptor-potential-like protein, transcript variant X2
transient-receptor-potential-like protein
insulin-like growth factor I, juvenile form
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ras-like protein family member 11B, transcript variant X2
ras-like protein family member 11B, transcript variant X1
ras-like protein family member 11B, transcript variant X3
ras-related and estrogen-regulated growth inhibitor isoform X1
ras-like protein family member 11B isoform X2
apoptosis-inducing factor 3, transcript variant X4
apoptosis-inducing factor 3, transcript variant X2
apoptosis-inducing factor 3, transcript variant X3
apoptosis-inducing factor 3, transcript variant X1
cytoplasmic polyadenylation element-binding protein 2
uncharacterized LOC105665985, transcript variant X2
uncharacterized LOC105665985, transcript variant X1
tubulin epsilon chain-like, transcript variant X2
tubulin epsilon chain-like, transcript variant X1
nuclear envelope integral membrane protein 1, transcript variant X1
nuclear envelope integral membrane protein 1, transcript variant X2
nuclear envelope integral membrane protein 1, transcript variant X3
nuclear envelope integral membrane protein 1 isoform X1
nuclear envelope integral membrane protein 1 isoform X2
nuclear envelope integral membrane protein 1 isoform X3
probable sodium/potassium/calcium exchanger CG1090, transcript variant X1
probable sodium/potassium/calcium exchanger CG1090, transcript variant X2
probable sodium/potassium/calcium exchanger CG1090
uncharacterized LOC100651685, transcript variant X1
uncharacterized LOC100651685, transcript variant X2
uncharacterized protein LOC100651685 isoform X2
uncharacterized protein LOC100651685 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
phosphomevalonate kinase; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001280916.1
annotated by transcript or proteomic data
The RefSeq transcript has 4 substitutions, 2 non-frameshifting indels and aligns at 98% coverage compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
Derived by automated computational analysis using gene prediction method: BestRefSeq.
calcium-independent phospholipase A2-gamma, transcript variant X2
calcium-independent phospholipase A2-gamma isoform X2
calcium-independent phospholipase A2-gamma, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 140 samples with support for all annotated introns
calcium-independent phospholipase A2-gamma isoform X3
calcium-independent phospholipase A2-gamma, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 62 samples with support for all annotated introns
calcium-independent phospholipase A2-gamma, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 116 samples with support for all annotated introns
calcium-independent phospholipase A2-gamma, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
calcium-independent phospholipase A2-gamma isoform X1
calcium-independent phospholipase A2-gamma isoform X4
calcium-independent phospholipase A2-gamma isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
splicing factor YJU2, transcript variant X1
splicing factor YJU2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 87% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 72 samples with support for all annotated introns
uncharacterized LOC100643244, transcript variant X3
uncharacterized LOC100643244, transcript variant X2
uncharacterized LOC100643244, transcript variant X1
uncharacterized LOC100643244, transcript variant X5
uncharacterized LOC100643244, transcript variant X4
FHIP family protein AAEL005291, transcript variant X2
FHIP family protein AAEL005291, transcript variant X1
FHIP family protein AAEL005291, transcript variant X3
FHIP family protein AAEL005291, transcript variant X4
FHIP family protein AAEL005291 isoform X1
FHIP family protein AAEL005291 isoform X2
FHIP family protein AAEL005291 isoform X3
RILP-like protein homolog, transcript variant X4
RILP-like protein homolog, transcript variant X3
RILP-like protein homolog, transcript variant X2
RILP-like protein homolog, transcript variant X1
microprocessor complex subunit DGCR8, transcript variant X1
microprocessor complex subunit DGCR8, transcript variant X3
microprocessor complex subunit DGCR8, transcript variant X2
microprocessor complex subunit DGCR8, transcript variant X4
microprocessor complex subunit DGCR8 isoform X1
microprocessor complex subunit DGCR8 isoform X2
ER degradation-enhancing alpha-mannosidase-like protein 2
vesicular inhibitory amino acid transporter
ubiquitin carboxyl-terminal hydrolase 20
eukaryotic translation initiation factor 2 subunit 1, transcript variant X2
eukaryotic translation initiation factor 2 subunit 1, transcript variant X4
eukaryotic translation initiation factor 2 subunit 1, transcript variant X3
eukaryotic translation initiation factor 2 subunit 1, transcript variant X1
eukaryotic translation initiation factor 2 subunit 1
sister chromatid cohesion protein PDS5 homolog B, transcript variant X1
sister chromatid cohesion protein PDS5 homolog B, transcript variant X3
sister chromatid cohesion protein PDS5 homolog B, transcript variant X2
sister chromatid cohesion protein PDS5 homolog B, transcript variant X4
sister chromatid cohesion protein PDS5 homolog B-B isoform X1
sister chromatid cohesion protein PDS5 homolog B isoform X3
sister chromatid cohesion protein PDS5 homolog B-B isoform X2
sister chromatid cohesion protein PDS5 homolog B isoform X4
probable ATP-dependent RNA helicase DDX27
flap endonuclease 1, transcript variant X2
flap endonuclease 1, transcript variant X1
flap endonuclease 1, transcript variant X3
reticulon-4-interacting protein 1 homolog, mitochondrial, transcript variant X1
reticulon-4-interacting protein 1 homolog, mitochondrial, transcript variant X2
reticulon-4-interacting protein 1 homolog, mitochondrial
uncharacterized LOC100644524, transcript variant X4
uncharacterized LOC100644524, transcript variant X2
uncharacterized LOC100644524, transcript variant X1
uncharacterized LOC100644524, transcript variant X3
uncharacterized LOC100644524, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
nucleolar protein 4-like, transcript variant X1
nucleolar protein 4-like, transcript variant X2
uncharacterized LOC100644889, transcript variant X1
uncharacterized LOC100644889, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 92% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC100645006, transcript variant X1
uncharacterized LOC100645006, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
ATP-dependent RNA helicase DDX24, transcript variant X3
ATP-dependent RNA helicase DDX24, transcript variant X2
ATP-dependent RNA helicase DDX24, transcript variant X1
ATP-dependent RNA helicase DDX24 isoform X2
ATP-dependent RNA helicase DDX24 isoform X1
ATP-dependent RNA helicase DDX24 isoform X3
conserved oligomeric Golgi complex subunit 8
39S ribosomal protein L48, mitochondrial, transcript variant X2
39S ribosomal protein L48, mitochondrial, transcript variant X1
39S ribosomal protein L48, mitochondrial isoform X1
39S ribosomal protein L48, mitochondrial isoform X2
WD repeat-containing and planar cell polarity effector protein fritz, transcript variant X5
WD repeat-containing and planar cell polarity effector protein fritz, transcript variant X2
WD repeat-containing and planar cell polarity effector protein fritz, transcript variant X1
WD repeat-containing and planar cell polarity effector protein fritz isoform X4
WD repeat-containing and planar cell polarity effector protein fritz isoform X1
WD repeat-containing and planar cell polarity effector protein fritz, transcript variant X3
WD repeat-containing and planar cell polarity effector protein fritz isoform X2
WD repeat-containing and planar cell polarity effector protein fritz, transcript variant X6
WD repeat-containing and planar cell polarity effector protein fritz, transcript variant X4
WD repeat-containing and planar cell polarity effector protein fritz homolog isoform X5
WD repeat-containing and planar cell polarity effector protein fritz isoform X3
uncharacterized LOC100644176, transcript variant X2
uncharacterized LOC100644176, transcript variant X1
uncharacterized protein LOC100644176 isoform X1
uncharacterized LOC100644176, transcript variant X3
uncharacterized protein LOC100644176 isoform X2
uncharacterized LOC100645597, transcript variant X2
uncharacterized LOC100645597, transcript variant X1
uncharacterized protein LOC100645597 isoform X1
uncharacterized protein LOC100645597 isoform X2
leucine-rich melanocyte differentiation-associated protein, transcript variant X2
leucine-rich melanocyte differentiation-associated protein, transcript variant X1
leucine-rich melanocyte differentiation-associated protein isoform X1
leucine-rich melanocyte differentiation-associated protein isoform X2
synaptic vesicle glycoprotein 2C, transcript variant X2
synaptic vesicle glycoprotein 2C isoform X2
synaptic vesicle glycoprotein 2C, transcript variant X3
synaptic vesicle glycoprotein 2C isoform X3
synaptic vesicle glycoprotein 2C, transcript variant X1
synaptic vesicle glycoprotein 2C isoform X1
synaptic vesicle glycoprotein 2C, transcript variant X4
synaptic vesicle glycoprotein 2C isoform X4
S phase cyclin A-associated protein in the endoplasmic reticulum, transcript variant X1
S phase cyclin A-associated protein in the endoplasmic reticulum, transcript variant X2
S phase cyclin A-associated protein in the endoplasmic reticulum
ubiquitin-conjugating enzyme E2 N, transcript variant X2
ubiquitin-conjugating enzyme E2 N, transcript variant X1
ubiquitin-conjugating enzyme E2 N, transcript variant X3
ras-specific guanine nucleotide-releasing factor 1, transcript variant X1
ras-specific guanine nucleotide-releasing factor 1, transcript variant X5
ras-specific guanine nucleotide-releasing factor 1, transcript variant X2
ras-specific guanine nucleotide-releasing factor 1, transcript variant X3
ras-specific guanine nucleotide-releasing factor 1, transcript variant X4
ras-specific guanine nucleotide-releasing factor 1 isoform X1
ras-specific guanine nucleotide-releasing factor 1 isoform X2
ras-specific guanine nucleotide-releasing factor 1 isoform X5
ras-specific guanine nucleotide-releasing factor 1 isoform X3
ras-specific guanine nucleotide-releasing factor 1 isoform X4
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X7
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X4
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X6
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X2
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X5
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X1
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X3
basement membrane-specific heparan sulfate proteoglycan core protein
uncharacterized LOC125385580, transcript variant X3
ATP-dependent helicase brm, transcript variant X8
uncharacterized LOC125385580, transcript variant X1
uncharacterized LOC125385580, transcript variant X2
ATP-dependent helicase brm, transcript variant X7
ATP-dependent helicase brm, transcript variant X6
ATP-dependent helicase brm, transcript variant X4
ATP-dependent helicase brm, transcript variant X3
ATP-dependent helicase brm, transcript variant X10
ATP-dependent helicase brm, transcript variant X9
ATP-dependent helicase brm, transcript variant X12
ATP-dependent helicase brm, transcript variant X1
ATP-dependent helicase brm, transcript variant X11
ATP-dependent helicase brm, transcript variant X5
ATP-dependent helicase brm, transcript variant X2
cysteine and histidine-rich protein 1 homolog
sporulation-specific protein 15, transcript variant X10
sporulation-specific protein 15, transcript variant X6
sporulation-specific protein 15, transcript variant X4
sporulation-specific protein 15, transcript variant X2
sporulation-specific protein 15, transcript variant X8
sporulation-specific protein 15, transcript variant X9
sporulation-specific protein 15, transcript variant X5
sporulation-specific protein 15, transcript variant X7
sporulation-specific protein 15, transcript variant X3
sporulation-specific protein 15, transcript variant X1
sporulation-specific protein 15 isoform X2
sporulation-specific protein 15 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
endoplasmic reticulum metallopeptidase 1, transcript variant X3
endoplasmic reticulum metallopeptidase 1, transcript variant X1
endoplasmic reticulum metallopeptidase 1, transcript variant X2
endoplasmic reticulum metallopeptidase 1
trimeric intracellular cation channel type 1B.1
uncharacterized LOC100644608, transcript variant X3
uncharacterized LOC100644608, transcript variant X2
uncharacterized LOC100644608, transcript variant X1
uncharacterized protein LOC100644608 isoform X3
uncharacterized protein LOC100644608 isoform X2
uncharacterized protein LOC100644608 isoform X1
uncharacterized LOC105665989, transcript variant X3
uncharacterized LOC105665989, transcript variant X2
uncharacterized LOC105665989, transcript variant X1
uncharacterized protein LOC105665989 isoform X3
uncharacterized protein LOC105665989 isoform X2
uncharacterized protein LOC105665989 isoform X1
mitogen-activated protein kinase p38b, transcript variant X2
mitogen-activated protein kinase p38b, transcript variant X1
mitogen-activated protein kinase p38b, transcript variant X3
mitogen-activated protein kinase p38b isoform X2
mitogen-activated protein kinase p38b isoform X1
mitogen-activated protein kinase p38a isoform X3
2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial, transcript variant X3
2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial, transcript variant X1
2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial, transcript variant X2
2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial isoform X1
2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial isoform X2
Golgi SNAP receptor complex member 1, transcript variant X1
Golgi SNAP receptor complex member 1, transcript variant X2
Golgi SNAP receptor complex member 1 isoform X1
Golgi SNAP receptor complex member 1 isoform X2
protein strawberry notch, transcript variant X2
protein strawberry notch, transcript variant X1
histone-lysine N-methyltransferase PR-Set7
vacuolar protein sorting-associated protein 26C
protein mono-ADP-ribosyltransferase PARP16, transcript variant X2
protein mono-ADP-ribosyltransferase PARP16, transcript variant X1
protein mono-ADP-ribosyltransferase PARP16
myocyte-specific enhancer factor 2, transcript variant X1
myocyte-specific enhancer factor 2, transcript variant X9
myocyte-specific enhancer factor 2, transcript variant X8
myocyte-specific enhancer factor 2, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
myocyte-specific enhancer factor 2, transcript variant X3
myocyte-specific enhancer factor 2, transcript variant X7
myocyte-specific enhancer factor 2, transcript variant X6
myocyte-specific enhancer factor 2, transcript variant X4
myocyte-specific enhancer factor 2, transcript variant X5
myocyte-specific enhancer factor 2, transcript variant X2
myocyte-specific enhancer factor 2 isoform X1
myocyte-specific enhancer factor 2 isoform X3
myocyte-specific enhancer factor 2 isoform X2
myocyte-specific enhancer factor 2 isoform X4
transient receptor potential cation channel trpm, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 63 samples with support for all annotated introns
transient receptor potential cation channel trpm isoform X2
transient receptor potential cation channel trpm isoform X5
transient receptor potential cation channel trpm isoform X1
transient receptor potential cation channel trpm isoform X3
transient receptor potential cation channel trpm isoform X7
transient receptor potential cation channel trpm isoform X4
transient receptor potential cation channel trpm isoform X6
transient receptor potential cation channel trpm isoform X8
transient receptor potential cation channel trpm, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
transient receptor potential cation channel trpm isoform X9
chymotrypsin-like elastase family member 2A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 431, transcript variant X1
zinc finger protein 431, transcript variant X2
zinc finger protein 431, transcript variant X4
zinc finger protein 431, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
39S ribosomal protein L39, mitochondrial, transcript variant X2
39S ribosomal protein L39, mitochondrial, transcript variant X1
39S ribosomal protein L39, mitochondrial
DNA-directed RNA polymerase III subunit RPC10
yrdC domain-containing protein, mitochondrial
spectrin beta chain, non-erythrocytic 5, transcript variant X4
jerky protein homolog-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 144 samples with support for all annotated introns
jerky protein homolog-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
jerky protein homolog-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 136 samples with support for all annotated introns
jerky protein homolog-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
spectrin beta chain, non-erythrocytic 5, transcript variant X1
spectrin beta chain, non-erythrocytic 5, transcript variant X2
spectrin beta chain, non-erythrocytic 5, transcript variant X3
spectrin beta chain, non-erythrocytic 5 isoform X1
spectrin beta chain, non-erythrocytic 5 isoform X3
spectrin beta chain, non-erythrocytic 5 isoform X2
spectrin beta chain, non-erythrocytic 5, transcript variant X5
spectrin beta chain, non-erythrocytic 5 isoform X4
uncharacterized LOC110119518, transcript variant X14
uncharacterized LOC110119518, transcript variant X11
uncharacterized LOC110119518, transcript variant X9
uncharacterized LOC110119518, transcript variant X6
uncharacterized LOC110119518, transcript variant X8
uncharacterized LOC110119518, transcript variant X3
uncharacterized LOC110119518, transcript variant X10
uncharacterized LOC110119518, transcript variant X2
uncharacterized LOC110119518, transcript variant X7
uncharacterized LOC110119518, transcript variant X12
uncharacterized LOC110119518, transcript variant X13
uncharacterized LOC110119518, transcript variant X5
uncharacterized LOC110119518, transcript variant X4
uncharacterized LOC110119518, transcript variant X1
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X1
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X2
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X4
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X3
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X5
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X7
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X6
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X8
mitogen-activated protein kinase kinase kinase kinase 5 isoform X1
mitogen-activated protein kinase kinase kinase kinase 5 isoform X3
mitogen-activated protein kinase kinase kinase kinase 5 isoform X2
mitogen-activated protein kinase kinase kinase kinase 5 isoform X4
mitogen-activated protein kinase kinase kinase kinase 5 isoform X6
mitogen-activated protein kinase kinase kinase kinase 5 isoform X5
mitogen-activated protein kinase kinase kinase kinase 5 isoform X7
pleckstrin homology domain-containing family G member 3, transcript variant X4
pleckstrin homology domain-containing family G member 3, transcript variant X1
pleckstrin homology domain-containing family G member 3, transcript variant X3
pleckstrin homology domain-containing family G member 3, transcript variant X2
pleckstrin homology domain-containing family G member 1 isoform X3
uncharacterized protein LOC100642211 isoform X1
uncharacterized protein LOC100642211 isoform X2
pleckstrin homology domain-containing family G member 3, transcript variant X5
uncharacterized protein LOC100642211 isoform X4
pleckstrin homology domain-containing family G member 3, transcript variant X7
pleckstrin homology domain-containing family G member 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 99 samples with support for all annotated introns
pleckstrin homology domain-containing family G member 3 isoform X5
uncharacterized LOC110119523, transcript variant X2
uncharacterized LOC110119523, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
ras-related protein Rap1, transcript variant X4
ras-related protein Rap1, transcript variant X3
ras-related protein Rap1, transcript variant X1
ras-related protein Rap1, transcript variant X2
IQ motif and SEC7 domain-containing protein 2, transcript variant X1
IQ motif and SEC7 domain-containing protein 2, transcript variant X6
IQ motif and SEC7 domain-containing protein 2, transcript variant X4
IQ motif and SEC7 domain-containing protein 2 isoform X1
IQ motif and SEC7 domain-containing protein 2 isoform X5
IQ motif and SEC7 domain-containing protein 2 isoform X3
IQ motif and SEC7 domain-containing protein 2, transcript variant X7
uncharacterized LOC105665996, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized LOC105665996, transcript variant X2
IQ motif and SEC7 domain-containing protein 2, transcript variant X5
IQ motif and SEC7 domain-containing protein 2 isoform X4
IQ motif and SEC7 domain-containing protein 2, transcript variant X2
IQ motif and SEC7 domain-containing protein 2, transcript variant X3
IQ motif and SEC7 domain-containing protein 1 isoform X2
IQ motif and SEC7 domain-containing protein 2 isoform X6
NAD-dependent protein deacylase Sirt4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 150 samples with support for all annotated introns
NAD-dependent protein deacylase Sirt4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 105 samples with support for all annotated introns
NAD-dependent protein deacylase Sirt4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
NAD-dependent protein deacylase Sirt4 isoform X1
NAD-dependent protein deacylase Sirt4 isoform X2
uncharacterized LOC100643205, transcript variant X2
uncharacterized LOC100643205, transcript variant X3
uncharacterized LOC100643205, transcript variant X4
uncharacterized LOC100643205, transcript variant X5
uncharacterized LOC100643205, transcript variant X9
uncharacterized LOC100643205, transcript variant X6
uncharacterized LOC100643205, transcript variant X1
uncharacterized LOC100643205, transcript variant X8
uncharacterized LOC100643205, transcript variant X7
uncharacterized protein LOC100643205 isoform X2
uncharacterized protein LOC100643205 isoform X5
uncharacterized protein LOC100643205 isoform X1
uncharacterized protein LOC100643205 isoform X4
uncharacterized protein LOC100643205 isoform X3
eukaryotic translation initiation factor 4E transporter, transcript variant X7
eukaryotic translation initiation factor 4E transporter, transcript variant X9
eukaryotic translation initiation factor 4E transporter, transcript variant X6
eukaryotic translation initiation factor 4E transporter, transcript variant X5
eukaryotic translation initiation factor 4E transporter, transcript variant X2
eukaryotic translation initiation factor 4E transporter, transcript variant X3
eukaryotic translation initiation factor 4E transporter, transcript variant X1
eukaryotic translation initiation factor 4E transporter, transcript variant X4
putative uncharacterized protein DDB_G0271606 isoform X7
eukaryotic translation initiation factor 4E transporter isoform X9
eukaryotic translation initiation factor 4E transporter isoform X6
eukaryotic translation initiation factor 4E transporter isoform X5
eukaryotic translation initiation factor 4E transporter isoform X2
putative uncharacterized protein DDB_G0271606 isoform X3
eukaryotic translation initiation factor 4E transporter isoform X4
eukaryotic translation initiation factor 4E transporter isoform X1
eukaryotic translation initiation factor 4E transporter, transcript variant X8
eukaryotic translation initiation factor 4E transporter isoform X8
sister chromatid cohesion protein PDS5 homolog C, transcript variant X2
sister chromatid cohesion protein PDS5 homolog C, transcript variant X1
sister chromatid cohesion protein PDS5 homolog C, transcript variant X3
sister chromatid cohesion protein PDS5 homolog C
coiled-coil domain-containing protein 174, transcript variant X2
coiled-coil domain-containing protein 174, transcript variant X1
coiled-coil domain-containing protein 174
non-structural maintenance of chromosomes element 1 homolog, transcript variant X7
non-structural maintenance of chromosomes element 1 homolog, transcript variant X2
non-structural maintenance of chromosomes element 1 homolog, transcript variant X8
non-structural maintenance of chromosomes element 1 homolog, transcript variant X4
non-structural maintenance of chromosomes element 1 homolog, transcript variant X3
non-structural maintenance of chromosomes element 1 homolog, transcript variant X1
non-structural maintenance of chromosomes element 1 homolog, transcript variant X5
non-structural maintenance of chromosomes element 1 homolog, transcript variant X6
non-structural maintenance of chromosomes element 1 homolog
calcium/calmodulin-dependent protein kinase type 1, transcript variant X1
calcium/calmodulin-dependent protein kinase type 1, transcript variant X2
calcium/calmodulin-dependent protein kinase type 1 isoform X1
calcium/calmodulin-dependent protein kinase type 1 isoform X2
eukaryotic translation initiation factor 3 subunit H
uncharacterized LOC100647734, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
uncharacterized LOC100647734, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 110 samples with support for all annotated introns
uncharacterized protein LOC100647734 isoform X1
uncharacterized protein LOC100647734 isoform X2
putative uncharacterized protein DDB_G0277255
plasminogen activator inhibitor 1 RNA-binding protein
integrator complex subunit 12, transcript variant X4
integrator complex subunit 12, transcript variant X1
integrator complex subunit 12, transcript variant X3
integrator complex subunit 12, transcript variant X2
integrator complex subunit 12 isoform X1
integrator complex subunit 12 isoform X3
integrator complex subunit 12 isoform X2
protein BCL9 homolog, transcript variant X1
protein BCL9 homolog, transcript variant X2
zinc finger Ran-binding domain-containing protein 2, transcript variant X5
zinc finger Ran-binding domain-containing protein 2, transcript variant X3
zinc finger Ran-binding domain-containing protein 2, transcript variant X4
zinc finger Ran-binding domain-containing protein 2, transcript variant X2
zinc finger Ran-binding domain-containing protein 2 isoform X2
zinc finger Ran-binding domain-containing protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 153 samples with support for all annotated introns
zinc finger Ran-binding domain-containing protein 2 isoform X1
ubiquitin-fold modifier 1, transcript variant X3
ubiquitin-fold modifier 1, transcript variant X2
ubiquitin-fold modifier 1, transcript variant X1
uncharacterized protein LOC100650963 isoform X1
uncharacterized LOC100650603, transcript variant X1
uncharacterized LOC100650603, transcript variant X2
uncharacterized protein LOC100650603 isoform X1
uncharacterized protein LOC100650603 isoform X2
uncharacterized LOC100651083, transcript variant X3
uncharacterized LOC100651083, transcript variant X1
uncharacterized LOC100651083, transcript variant X4
uncharacterized LOC100651083, transcript variant X2
uncharacterized protein LOC100651083 isoform X2
uncharacterized protein LOC100651083 isoform X1
arginine/serine-rich coiled-coil protein 2
acidic phospholipase A2 PA4, transcript variant X2
acidic phospholipase A2 PA4, transcript variant X3
acidic phospholipase A2 PA4, transcript variant X1
LIM domain kinase 1, transcript variant X2
LIM domain kinase 1, transcript variant X1
LIM domain kinase 1, transcript variant X4
LIM domain kinase 1, transcript variant X3
uncharacterized LOC110119500, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
uncharacterized LOC110119500, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC105666001, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC105666001, transcript variant X3
uncharacterized LOC105666001, transcript variant X2
uncharacterized LOC105666001, transcript variant X4
optomotor-blind protein, transcript variant X3
optomotor-blind protein, transcript variant X1
optomotor-blind protein, transcript variant X2
coiled-coil domain-containing protein 86
uncharacterized LOC100642847, transcript variant X2
uncharacterized LOC100642847, transcript variant X1
uncharacterized LOC100642965, transcript variant X2
uncharacterized LOC100642965, transcript variant X4
uncharacterized LOC100642965, transcript variant X3
uncharacterized LOC100642965, transcript variant X1
uncharacterized protein LOC100642965 isoform X2
uncharacterized protein LOC100642965 isoform X1
uncharacterized protein LOC100642965 isoform X3
U3 small nucleolar ribonucleoprotein protein MPP10
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X6
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X8
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X7
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X5
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X2
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X3
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X4
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X1
aryl hydrocarbon receptor nuclear translocator homolog isoform X7
aryl hydrocarbon receptor nuclear translocator homolog isoform X6
aryl hydrocarbon receptor nuclear translocator homolog isoform X5
aryl hydrocarbon receptor nuclear translocator homolog isoform X8
aryl hydrocarbon receptor nuclear translocator homolog isoform X2
aryl hydrocarbon receptor nuclear translocator homolog isoform X3
aryl hydrocarbon receptor nuclear translocator homolog isoform X4
aryl hydrocarbon receptor nuclear translocator homolog isoform X1
coiled-coil domain-containing protein 112-like
GAS2-like protein pickled eggs, transcript variant X1
GAS2-like protein pickled eggs, transcript variant X2
GAS2-like protein pickled eggs isoform X1
GAS2-like protein pickled eggs isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC105666003, transcript variant X1
uncharacterized LOC105666003, transcript variant X2
uncharacterized LOC100648209, transcript variant X2
uncharacterized LOC100648209, transcript variant X1
uncharacterized LOC100648209, transcript variant X3
uncharacterized LOC100648209, transcript variant X4
uncharacterized protein LOC100648209 isoform X1
uncharacterized protein LOC100648209 isoform X2
uncharacterized protein LOC100648209 isoform X3
mitochondrial amidoxime-reducing component 1, transcript variant X2
mitochondrial amidoxime-reducing component 1, transcript variant X1
mitochondrial amidoxime-reducing component 1, transcript variant X4
mitochondrial amidoxime-reducing component 1 isoform X2
mitochondrial amidoxime-reducing component 1 isoform X1
mitochondrial amidoxime-reducing component 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 147 samples with support for all annotated introns
mitochondrial amidoxime-reducing component 1 isoform X3
protein kinase C-binding protein NELL1, transcript variant X1
protein kinase C-binding protein NELL1, transcript variant X4
protein kinase C-binding protein NELL1, transcript variant X2
protein kinase C-binding protein NELL1, transcript variant X3
protein kinase C-binding protein NELL1 isoform X4
protein kinase C-binding protein NELL1 isoform X1
protein kinase C-binding protein NELL1 isoform X3
protein kinase C-binding protein NELL1 isoform X2
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1, transcript variant X5
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1, transcript variant X4
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1, transcript variant X2
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1, transcript variant X1
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 isoform X2
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 62 samples with support for all annotated introns
leucine-rich repeat-containing protein 24 isoform X1
putative carbonic anhydrase-like protein 2, transcript variant X1
putative carbonic anhydrase-like protein 2, transcript variant X2
putative carbonic anhydrase-like protein 2, transcript variant X3
carbonic anhydrase-related protein 10 isoform X1
putative carbonic anhydrase-like protein 2, transcript variant X4
putative carbonic anhydrase-like protein 2 isoform X2
uncharacterized LOC125385544, transcript variant X2
uncharacterized LOC125385544, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC125385544, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
peptide-N(4)-(N-acetyl-beta- glucosaminyl)asparagine amidase, transcript variant X1
peptide-N(4)-(N-acetyl-beta- glucosaminyl)asparagine amidase, transcript variant X2
peptide-N(4)-(N-acetyl-beta- glucosaminyl)asparagine amidase
ubiquitin carboxyl-terminal hydrolase 8, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 8, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 8 isoform X1
ubiquitin carboxyl-terminal hydrolase 8 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
alpha-ketoglutarate-dependent dioxygenase alkB homolog 6
lisH domain-containing protein ARMC9, transcript variant X1
lisH domain-containing protein ARMC9, transcript variant X2
lisH domain-containing protein ARMC9, transcript variant X6
lisH domain-containing protein ARMC9, transcript variant X4
lisH domain-containing protein ARMC9, transcript variant X3
lisH domain-containing protein ARMC9 isoform X1
lisH domain-containing protein ARMC9 isoform X2
lisH domain-containing protein ARMC9 isoform X6
lisH domain-containing protein ARMC9 isoform X4
lisH domain-containing protein ARMC9 isoform X3
lisH domain-containing protein ARMC9, transcript variant X5
lisH domain-containing protein ARMC9 isoform X5
putative uncharacterized protein DDB_G0282133
uncharacterized LOC100651643, transcript variant X1
uncharacterized LOC100651643, transcript variant X2
uncharacterized protein LOC100651643 isoform X2
uncharacterized protein LOC100651643 isoform X1
E3 ubiquitin-protein ligase HUWE1, transcript variant X2
E3 ubiquitin-protein ligase HUWE1, transcript variant X3
E3 ubiquitin-protein ligase HUWE1, transcript variant X1
E3 ubiquitin-protein ligase HUWE1 isoform X2
E3 ubiquitin-protein ligase HUWE1 isoform X3
E3 ubiquitin-protein ligase HUWE1 isoform X1
uncharacterized LOC100652078, transcript variant X1
uncharacterized protein LOC100652078 isoform X1
uncharacterized LOC100652078, transcript variant X2
uncharacterized protein LOC100652078 isoform X2
methylated-DNA--protein-cysteine methyltransferase, inducible
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC105666005, transcript variant X2
uncharacterized LOC105666005, transcript variant X1
uncharacterized LOC125385563, transcript variant X2
uncharacterized LOC125385563, transcript variant X1
uncharacterized protein LOC125385563 isoform X1
uncharacterized protein LOC125385563 isoform X2
phenylalanine--tRNA ligase alpha subunit, transcript variant X1
phenylalanine--tRNA ligase alpha subunit isoform X1
phenylalanine--tRNA ligase alpha subunit, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 120 samples with support for all annotated introns
phenylalanine--tRNA ligase alpha subunit, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 137 samples with support for all annotated introns
phenylalanine--tRNA ligase alpha subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
phenylalanine--tRNA ligase alpha subunit isoform X2
phenylalanine--tRNA ligase alpha subunit isoform X3
L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase
dynein axonemal intermediate chain 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
dynein axonemal intermediate chain 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
dynein axonemal intermediate chain 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dynein axonemal intermediate chain 3 isoform X1
dynein axonemal intermediate chain 3 isoform X3
dynein axonemal intermediate chain 3 isoform X2
superoxide dismutase [Cu-Zn], chloroplastic
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
S-adenosylmethionine mitochondrial carrier protein
hydroxysteroid dehydrogenase-like protein 2
asparagine synthetase domain-containing protein 1, transcript variant X2
asparagine synthetase domain-containing protein 1, transcript variant X1
asparagine synthetase domain-containing protein 1
uncharacterized LOC100643452, transcript variant X2
uncharacterized LOC100643452, transcript variant X1
ADP-ribosylhydrolase ARH3, transcript variant X1
ADP-ribosylhydrolase ARH3, transcript variant X2
Kv channel-interacting protein 1, transcript variant X2
Kv channel-interacting protein 1, transcript variant X1
dynein regulatory complex subunit 5, transcript variant X3
dynein regulatory complex subunit 5, transcript variant X2
dynein regulatory complex subunit 5, transcript variant X1
dynein regulatory complex subunit 5 isoform X2
dynein regulatory complex subunit 5 isoform X1
serine/threonine-protein kinase 11-interacting protein, transcript variant X4
serine/threonine-protein kinase 11-interacting protein, transcript variant X5
serine/threonine-protein kinase 11-interacting protein, transcript variant X6
serine/threonine-protein kinase 11-interacting protein, transcript variant X3
serine/threonine-protein kinase 11-interacting protein, transcript variant X1
serine/threonine-protein kinase 11-interacting protein, transcript variant X8
serine/threonine-protein kinase 11-interacting protein, transcript variant X9
serine/threonine-protein kinase 11-interacting protein, transcript variant X7
serine/threonine-protein kinase 11-interacting protein, transcript variant X10
serine/threonine-protein kinase 11-interacting protein, transcript variant X2
serine/threonine-protein kinase 11-interacting protein isoform X1
serine/threonine-protein kinase 11-interacting protein isoform X3
serine/threonine-protein kinase 11-interacting protein isoform X4
serine/threonine-protein kinase 11-interacting protein isoform X2
serine/threonine-protein kinase 11-interacting protein isoform X5
vacuolar protein sorting-associated protein 13, transcript variant X1
vacuolar protein sorting-associated protein 13, transcript variant X2
vacuolar protein sorting-associated protein 13, transcript variant X3
vacuolar protein sorting-associated protein 13, transcript variant X4
vacuolar protein sorting-associated protein 13 isoform X1
vacuolar protein sorting-associated protein 13 isoform X2
vacuolar protein sorting-associated protein 13 isoform X3
vacuolar protein sorting-associated protein 13 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 94% coverage of the annotated genomic feature by RNAseq alignments
proton-associated sugar transporter A, transcript variant X3
proton-associated sugar transporter A, transcript variant X2
proton-associated sugar transporter A, transcript variant X1
proton-associated sugar transporter A isoform X3
proton-associated sugar transporter A isoform X1
proton-associated sugar transporter A isoform X2
synaptic vesicle glycoprotein 2A, transcript variant X2
synaptic vesicle glycoprotein 2A, transcript variant X1
synaptic vesicle glycoprotein 2A isoform X1
synaptic vesicle glycoprotein 2A, transcript variant X3
synaptic vesicle glycoprotein 2A isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 75 samples with support for all annotated introns
citron Rho-interacting kinase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 93 samples with support for all annotated introns
citron Rho-interacting kinase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 74 samples with support for all annotated introns
citron Rho-interacting kinase isoform X2
citron Rho-interacting kinase isoform X1
bromodomain-containing protein DDB_G0280777, transcript variant X5
bromodomain-containing protein DDB_G0280777, transcript variant X4
bromodomain-containing protein DDB_G0280777, transcript variant X3
bromodomain-containing protein DDB_G0280777, transcript variant X6
bromodomain-containing protein DDB_G0280777, transcript variant X2
bromodomain-containing protein DDB_G0280777, transcript variant X1
bromodomain-containing protein DDB_G0280777 isoform X1
bromodomain-containing protein DDB_G0280777 isoform X2
calcium release-activated calcium channel protein 1, transcript variant X1
calcium release-activated calcium channel protein 1, transcript variant X2
calcium release-activated calcium channel protein 1
signal peptide peptidase-like 3, transcript variant X1
signal peptide peptidase-like 3, transcript variant X2
signal peptide peptidase-like 3, transcript variant X3
signal peptide peptidase-like 3, transcript variant X4
oxysterol-binding protein 1, transcript variant X1
oxysterol-binding protein 1, transcript variant X2
oxysterol-binding protein 1, transcript variant X3
oxysterol-binding protein 1, transcript variant X4
general transcription factor IIH subunit 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform, transcript variant X1
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform isoform X1
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform, transcript variant X2
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform isoform X2
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform, transcript variant X3
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform isoform X3
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform, transcript variant X4
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform isoform X4
venom dipeptidyl peptidase 4, transcript variant X5
venom dipeptidyl peptidase 4, transcript variant X4
venom dipeptidyl peptidase 4, transcript variant X2
venom dipeptidyl peptidase 4, transcript variant X3
venom dipeptidyl peptidase 4, transcript variant X1
DNA-directed RNA polymerase I subunit RPA12
F-box/SPRY domain-containing protein 1, transcript variant X1
F-box/SPRY domain-containing protein 1, transcript variant X2
F-box/SPRY domain-containing protein 1 isoform X1
F-box/SPRY domain-containing protein 1 isoform X2
transmembrane protein 164, transcript variant X2
transmembrane protein 164, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
pleckstrin homology domain-containing family G member 5, transcript variant X8
pleckstrin homology domain-containing family G member 5, transcript variant X7
pleckstrin homology domain-containing family G member 5, transcript variant X4
pleckstrin homology domain-containing family G member 5, transcript variant X1
pleckstrin homology domain-containing family G member 5, transcript variant X3
pleckstrin homology domain-containing family G member 5, transcript variant X5
pleckstrin homology domain-containing family G member 5, transcript variant X2
pleckstrin homology domain-containing family G member 5, transcript variant X11
pleckstrin homology domain-containing family G member 5, transcript variant X6
pleckstrin homology domain-containing family G member 5, transcript variant X9
pleckstrin homology domain-containing family G member 5, transcript variant X10
pleckstrin homology domain-containing family G member 5 isoform X1
pleckstrin homology domain-containing family G member 5 isoform X2
pleckstrin homology domain-containing family G member 5 isoform X5
pleckstrin homology domain-containing family G member 5 isoform X4
pleckstrin homology domain-containing family G member 5 isoform X6
pleckstrin homology domain-containing family G member 5 isoform X3
pleckstrin homology domain-containing family G member 5 isoform X7
pleckstrin homology domain-containing family G member 5, transcript variant X12
pleckstrin homology domain-containing family G member 5 isoform X8
leucine-zipper-like transcriptional regulator 1, transcript variant X2
leucine-zipper-like transcriptional regulator 1, transcript variant X1
leucine-zipper-like transcriptional regulator 1 homolog isoform X2
leucine-zipper-like transcriptional regulator 1 isoform X1
transfer RNA serine (anticodon GCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
molybdenum cofactor sulfurase 1, transcript variant X1
molybdenum cofactor sulfurase 1, transcript variant X2
molybdenum cofactor sulfurase 1 isoform X1
molybdenum cofactor sulfurase 1 isoform X2
molybdenum cofactor sulfurase 1, transcript variant X3
molybdenum cofactor sulfurase isoform X3
protein artichoke, transcript variant X4
protein artichoke, transcript variant X3
protein artichoke, transcript variant X2
protein artichoke, transcript variant X1
protein artichoke, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
signal peptidase complex catalytic subunit SEC11A
disintegrin and metalloproteinase domain-containing protein 10, transcript variant X1
disintegrin and metalloproteinase domain-containing protein 10, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 10
LIM domain-binding protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 127 samples with support for all annotated introns
LIM domain-binding protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 114 samples with support for all annotated introns
LIM domain-binding protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 115 samples with support for all annotated introns
uncharacterized LOC125385542, transcript variant X1
uncharacterized LOC125385542, transcript variant X2
uncharacterized LOC125385542, transcript variant X3
mastermind-like domain-containing protein 1, transcript variant X3
mastermind-like domain-containing protein 1, transcript variant X1
mastermind-like domain-containing protein 1, transcript variant X2
mastermind-like domain-containing protein 1, transcript variant X4
mastermind-like domain-containing protein 1, transcript variant X5
mastermind-like domain-containing protein 1 isoform X3
mastermind-like domain-containing protein 1 isoform X2
mastermind-like domain-containing protein 1 isoform X4
mastermind-like domain-containing protein 1 isoform X5
uncharacterized LOC110119486, transcript variant X2
uncharacterized LOC110119486, transcript variant X1
uncharacterized protein LOC110119486 isoform X1
uncharacterized protein LOC110119486 isoform X2
transmembrane protein 230, transcript variant X1
transmembrane protein 230, transcript variant X2
phenoloxidase-activating factor 2, transcript variant X3
phenoloxidase-activating factor 2, transcript variant X1
phenoloxidase-activating factor 2, transcript variant X2
phenoloxidase-activating factor 2 isoform X2
phenoloxidase-activating factor 2 isoform X1
phenoloxidase-activating factor 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC100642212, transcript variant X9
uncharacterized LOC100642212, transcript variant X1
uncharacterized LOC100642212, transcript variant X8
uncharacterized LOC100642212, transcript variant X2
uncharacterized LOC100642212, transcript variant X5
uncharacterized LOC100642212, transcript variant X3
uncharacterized LOC100642212, transcript variant X7
uncharacterized LOC100642212, transcript variant X6
uncharacterized LOC100642212, transcript variant X4
uncharacterized protein LOC100642212 isoform X2
uncharacterized protein LOC100642212 isoform X1
conserved oligomeric Golgi complex subunit 7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
uncharacterized LOC100643206, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
uncharacterized LOC100643206, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized LOC100643206, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC100643206, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
uncharacterized LOC100643206, transcript variant X2
uncharacterized LOC100643206, transcript variant X5
uncharacterized protein LOC100643206 isoform X1
uncharacterized protein LOC100643206 isoform X3
uncharacterized protein LOC100643206 isoform X2
probable JmjC domain-containing histone demethylation protein 2C, transcript variant X1
probable JmjC domain-containing histone demethylation protein 2C, transcript variant X5
probable JmjC domain-containing histone demethylation protein 2C, transcript variant X2
probable JmjC domain-containing histone demethylation protein 2C, transcript variant X4
probable JmjC domain-containing histone demethylation protein 2C isoform X1
probable JmjC domain-containing histone demethylation protein 2C isoform X5
probable JmjC domain-containing histone demethylation protein 2C isoform X4
probable JmjC domain-containing histone demethylation protein 2C isoform X2
probable JmjC domain-containing histone demethylation protein 2C, transcript variant X3
probable JmjC domain-containing histone demethylation protein 2C isoform X3
tyrosine-protein phosphatase non-receptor type 9
uncharacterized LOC105666015, transcript variant X4
uncharacterized LOC105666015, transcript variant X1
uncharacterized LOC105666015, transcript variant X3
uncharacterized LOC105666015, transcript variant X2
myogenesis-regulating glycosidase, transcript variant X1
uncharacterized protein LOC100643654 isoform X1
nucleoside diphosphate kinase homolog 5, transcript variant X1
nucleoside diphosphate kinase homolog 5, transcript variant X2
nucleoside diphosphate kinase homolog 5, transcript variant X3
nucleoside diphosphate kinase homolog 5 isoform X3
nucleoside diphosphate kinase homolog 5 isoform X2
nucleoside diphosphate kinase homolog 5 isoform X1
myogenesis-regulating glycosidase, transcript variant X2
myogenesis-regulating glycosidase isoform X2
uncharacterized LOC100644564, transcript variant X1
uncharacterized LOC100644564, transcript variant X2
uncharacterized LOC100644564, transcript variant X3
uncharacterized protein LOC100644564 isoform X1
uncharacterized LOC100644564, transcript variant X4
uncharacterized protein LOC100644564 isoform X2
beta-1,4-galactosyltransferase 7, transcript variant X3
beta-1,4-galactosyltransferase 7, transcript variant X2
beta-1,4-galactosyltransferase 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
probable 39S ribosomal protein L45, mitochondrial, transcript variant X1
probable 39S ribosomal protein L45, mitochondrial, transcript variant X2
probable 39S ribosomal protein L45, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
glutamate receptor ionotropic, kainate glr-3
tyrosine-protein kinase transmembrane receptor Ror, transcript variant X1
tyrosine-protein kinase transmembrane receptor Ror, transcript variant X3
tyrosine-protein kinase transmembrane receptor Ror isoform X1
tyrosine-protein kinase transmembrane receptor Ror isoform X3
tyrosine-protein kinase transmembrane receptor Ror, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 66 samples with support for all annotated introns
tyrosine-protein kinase transmembrane receptor Ror isoform X2
uncharacterized LOC105666016, transcript variant X2
uncharacterized LOC105666016, transcript variant X1
uncharacterized protein LOC105666016 isoform X1
uncharacterized protein LOC105666016 isoform X2
uncharacterized LOC105666016, transcript variant X3
uncharacterized LOC105666016, transcript variant X4
uncharacterized protein LOC105666016 isoform X3
uncharacterized LOC105666016, transcript variant X5
uncharacterized protein LOC105666016 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93% coverage of the annotated genomic feature by RNAseq alignments
protein O-GlcNAcase, transcript variant X2
protein O-GlcNAcase, transcript variant X3
protein O-GlcNAcase, transcript variant X1
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2, transcript variant X12
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2, transcript variant X1
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2, transcript variant X8
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2, transcript variant X5
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2, transcript variant X6
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2, transcript variant X2
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2, transcript variant X3
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2, transcript variant X4
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2, transcript variant X7
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2, transcript variant X9
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2, transcript variant X10
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 isoform X1
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 isoform X2
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 isoform X6
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 isoform X3
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 isoform X5
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 isoform X7
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 isoform X8
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 isoform X4
uncharacterized protein LOC100645915 isoform X10
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2, transcript variant X11
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 isoform X9
zinc finger HIT domain-containing protein 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: phosphatidylinositol 4-kinase alpha
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7
superoxide dismutase [Cu-Zn], transcript variant X1
superoxide dismutase [Cu-Zn], transcript variant X2
uncharacterized LOC100646866, transcript variant X1
uncharacterized LOC100646866, transcript variant X2
uncharacterized protein LOC100646866 isoform X1
uncharacterized LOC100646866, transcript variant X3
uncharacterized protein LOC100646866 isoform X2
uncharacterized LOC100647103, transcript variant X9
uncharacterized LOC100647103, transcript variant X8
uncharacterized LOC100647103, transcript variant X7
uncharacterized LOC100647103, transcript variant X6
uncharacterized LOC100647103, transcript variant X5
uncharacterized protein LOC100647103 isoform X2
uncharacterized LOC100647103, transcript variant X4
uncharacterized LOC100647103, transcript variant X2
uncharacterized LOC100647103, transcript variant X1
uncharacterized LOC100647103, transcript variant X3
uncharacterized protein LOC100647103 isoform X1
BTB/POZ domain-containing protein 7, transcript variant X2
BTB/POZ domain-containing protein 7, transcript variant X4
BTB/POZ domain-containing protein 7, transcript variant X5
BTB/POZ domain-containing protein 7, transcript variant X1
BTB/POZ domain-containing protein 7, transcript variant X3
BTB/POZ domain-containing protein 7 isoform X2
BTB/POZ domain-containing protein 7 isoform X1
GTP-binding protein 2, transcript variant X2
GTP-binding protein 2, transcript variant X5
GTP-binding protein 2, transcript variant X6
GTP-binding protein 2, transcript variant X4
uncharacterized LOC100647465, transcript variant X2
uncharacterized LOC100647465, transcript variant X1
GTP-binding protein 2, transcript variant X1
GTP-binding protein 2, transcript variant X3
leukocyte elastase inhibitor, transcript variant X2
leukocyte elastase inhibitor, transcript variant X4
leukocyte elastase inhibitor, transcript variant X1
leukocyte elastase inhibitor, transcript variant X3
uncharacterized LOC110119504, transcript variant X1
uncharacterized LOC110119504, transcript variant X2
cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1-like
nudC domain-containing protein 1, transcript variant X2
nudC domain-containing protein 1, transcript variant X1
nudC domain-containing protein 1 isoform X2
nudC domain-containing protein 1 isoform X1
uncharacterized protein LOC100646420 isoform X3
uncharacterized protein LOC100646420 isoform X5
uncharacterized protein LOC100646420 isoform X2
uncharacterized protein LOC100646420 isoform X4
uncharacterized protein LOC100646420 isoform X1
uncharacterized protein LOC100646420 isoform X6
protein unc-13 homolog 4B, transcript variant X2
protein unc-13 homolog 4B, transcript variant X1
protein unc-13 homolog 4B, transcript variant X3
protein unc-13 homolog 4B, transcript variant X5
protein unc-13 homolog 4B, transcript variant X4
protein unc-13 homolog 4B, transcript variant X9
protein unc-13 homolog 4B, transcript variant X7
protein unc-13 homolog 4B, transcript variant X6
protein unc-13 homolog 4B, transcript variant X8
uncharacterized LOC110119488, transcript variant X1
uncharacterized LOC110119488, transcript variant X2
uncharacterized protein LOC110119488 isoform X1
uncharacterized protein LOC110119488 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
uncharacterized LOC100645411, transcript variant X1
uncharacterized protein LOC100645411 isoform X1
uncharacterized LOC100645411, transcript variant X2
uncharacterized protein LOC100645411 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
transfer RNA isoleucine (anticodon AAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
mitotic spindle assembly checkpoint protein MAD1, transcript variant X7
mitotic spindle assembly checkpoint protein MAD1, transcript variant X1
mitotic spindle assembly checkpoint protein MAD1, transcript variant X6
mitotic spindle assembly checkpoint protein MAD1, transcript variant X3
mitotic spindle assembly checkpoint protein MAD1, transcript variant X5
mitotic spindle assembly checkpoint protein MAD1, transcript variant X2
mitotic spindle assembly checkpoint protein MAD1, transcript variant X4
mitotic spindle assembly checkpoint protein MAD1, transcript variant X8
mitotic spindle assembly checkpoint protein MAD1 isoform X1
mitotic spindle assembly checkpoint protein MAD1 isoform X2
mitotic spindle assembly checkpoint protein MAD1 isoform X3
mitotic spindle assembly checkpoint protein MAD1 isoform X4
GATOR complex protein WDR24, transcript variant X2
GATOR complex protein WDR24, transcript variant X1
GATOR complex protein WDR24, transcript variant X4
GATOR complex protein WDR24, transcript variant X3
gamma-aminobutyric acid type B receptor subunit 2, transcript variant X1
gamma-aminobutyric acid type B receptor subunit 2, transcript variant X2
gamma-aminobutyric acid type B receptor subunit 2 isoform X1
gamma-aminobutyric acid type B receptor subunit 2 isoform X2
glucose dehydrogenase [FAD, quinone], transcript variant X1
glucose dehydrogenase [FAD, quinone], transcript variant X3
glucose dehydrogenase [FAD, quinone], transcript variant X2
glucose dehydrogenase [FAD, quinone], transcript variant X4
glucose dehydrogenase [FAD, quinone] isoform X1
glucose dehydrogenase [FAD, quinone] isoform X2
rh5-interacting protein, transcript variant X3
rh5-interacting protein, transcript variant X1
rh5-interacting protein, transcript variant X2
prion-like-(Q/N-rich) domain-bearing protein 25
39S ribosomal protein L51, mitochondrial
uncharacterized LOC110120235, transcript variant X1
uncharacterized LOC110120235, transcript variant X2
RNA-binding protein Musashi homolog 2, transcript variant X5
RNA-binding protein Musashi homolog 2, transcript variant X3
RNA-binding protein Musashi homolog 2, transcript variant X4
RNA-binding protein Musashi homolog 2, transcript variant X2
RNA-binding protein Musashi homolog 2, transcript variant X7
RNA-binding protein Musashi homolog 2, transcript variant X1
RNA-binding protein Musashi homolog 2, transcript variant X6
RNA-binding protein Musashi homolog 2, transcript variant X10
RNA-binding protein Musashi homolog 2, transcript variant X9
RNA-binding protein Musashi homolog 2, transcript variant X8
RNA-binding protein Musashi homolog 2, transcript variant X15
RNA-binding protein Musashi homolog 2, transcript variant X13
RNA-binding protein Musashi homolog 2, transcript variant X11
RNA-binding protein Musashi homolog 2, transcript variant X14
RNA-binding protein Musashi homolog 2, transcript variant X12
RNA-binding protein Musashi homolog 2 isoform X1
RNA-binding protein Musashi homolog 2 isoform X2
RNA-binding protein Musashi homolog 2 isoform X3
RNA-binding protein Musashi homolog 2 isoform X4
uncharacterized LOC110120235, transcript variant X3
uncharacterized LOC110120235, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
retinol dehydrogenase 14, transcript variant X1
retinol dehydrogenase 14, transcript variant X3
retinol dehydrogenase 14, transcript variant X4
retinol dehydrogenase 14, transcript variant X2
retinol dehydrogenase 14, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
octopamine receptor beta-2R, transcript variant X4
octopamine receptor beta-2R, transcript variant X5
octopamine receptor beta-2R, transcript variant X3
octopamine receptor beta-2R, transcript variant X2
octopamine receptor beta-2R, transcript variant X1
octopamine receptor beta-2R, transcript variant X6
uncharacterized LOC125385531, transcript variant X2
uncharacterized LOC125385531, transcript variant X3
uncharacterized LOC125385531, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 104 samples with support for all annotated introns
uncharacterized LOC110120095, transcript variant X2
uncharacterized LOC110120095, transcript variant X1
uncharacterized LOC110120095, transcript variant X3
BTB/POZ domain-containing protein KCTD9, transcript variant X2
BTB/POZ domain-containing protein KCTD9, transcript variant X1
BTB/POZ domain-containing protein KCTD9, transcript variant X4
BTB/POZ domain-containing protein KCTD9, transcript variant X3
BTB/POZ domain-containing protein KCTD9, transcript variant X6
BTB/POZ domain-containing protein KCTD9, transcript variant X5
BTB/POZ domain-containing protein KCTD9 isoform X2
BTB/POZ domain-containing protein KCTD9 isoform X1
BTB/POZ domain-containing protein KCTD9 isoform X4
BTB/POZ domain-containing protein KCTD9 isoform X3
BTB/POZ domain-containing protein KCTD9 isoform X5
myb-like protein X, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
myb-like protein X, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
myb-like protein X, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 145 samples with support for all annotated introns
ATP-dependent RNA helicase SUV3 homolog, mitochondrial, transcript variant X1
ATP-dependent RNA helicase SUV3 homolog, mitochondrial, transcript variant X2
ATP-dependent RNA helicase SUV3 homolog, mitochondrial isoform X1
ATP-dependent RNA helicase SUV3 homolog, mitochondrial isoform X2
uncharacterized LOC100646567, transcript variant X2
uncharacterized LOC100646567, transcript variant X1
CDK5 regulatory subunit-associated protein 3, transcript variant X1
CDK5 regulatory subunit-associated protein 3, transcript variant X2
CDK5 regulatory subunit-associated protein 3 isoform X1
transmembrane emp24 domain-containing protein 7, transcript variant X2
transmembrane emp24 domain-containing protein 7, transcript variant X1
transmembrane emp24 domain-containing protein 7 isoform X2
transmembrane emp24 domain-containing protein 7 isoform X1
uncharacterized LOC100644421, transcript variant X1
uncharacterized LOC100644421, transcript variant X5
uncharacterized LOC100644421, transcript variant X6
uncharacterized LOC100644421, transcript variant X3
uncharacterized LOC100644421, transcript variant X7
uncharacterized LOC100644421, transcript variant X8
uncharacterized LOC100644421, transcript variant X9
uncharacterized LOC100644421, transcript variant X11
uncharacterized LOC100644421, transcript variant X2
uncharacterized protein LOC100644421 isoform X1
uncharacterized protein LOC100644421 isoform X6
uncharacterized protein LOC100644421 isoform X4
uncharacterized protein LOC100644421 isoform X7
uncharacterized protein LOC100644421 isoform X5
uncharacterized protein LOC100644421 isoform X8
uncharacterized protein LOC100644421 isoform X2
uncharacterized protein LOC100644421 isoform X10
uncharacterized LOC100644421, transcript variant X4
uncharacterized protein LOC100644421 isoform X3
uncharacterized LOC100644421, transcript variant X10
uncharacterized protein LOC100644421 isoform X9
28S ribosomal protein S27, mitochondrial
coiled-coil domain-containing protein 22 homolog
DENN domain-containing protein 5B, transcript variant X3
DENN domain-containing protein 5B, transcript variant X1
DENN domain-containing protein 5B, transcript variant X4
DENN domain-containing protein 5B, transcript variant X2
DENN domain-containing protein 5B isoform X3
DENN domain-containing protein 5A isoform X1
DENN domain-containing protein 5B isoform X4
DENN domain-containing protein 5A isoform X2
facilitated trehalose transporter Tret1-like, transcript variant X2
facilitated trehalose transporter Tret1-like, transcript variant X1
facilitated trehalose transporter Tret1-like isoform X2
facilitated trehalose transporter Tret1-like isoform X1
inositol monophosphatase 2, transcript variant X2
inositol monophosphatase 2, transcript variant X1
inositol monophosphatase 2, transcript variant X3
uncharacterized LOC100646761, transcript variant X1
uncharacterized LOC100646761, transcript variant X2
uncharacterized LOC100646761, transcript variant X3